Aliases & Classifications for Syncope

About this section

Aliases & Descriptions for Syncope:

Name: Syncope 49 27 2

Summaries for Syncope

About this section
NINDS:49 Syncope is a medical term used to describe a temporary loss of consciousness due to the sudden decline of blood flow to the brain. Syncope is commonly called fainting or “passing out.” If an individual is about to faint, he or she will feel dizzy, lightheaded, or nauseous and their field of vision may “white out” or “black out.”  The skin may be cold and clammy.  The person drops to the floor as he or she loses consciousness.  After fainting, an individual may be unconscious for a minute or two, but will revive and slowly return to normal.  Syncope can occur in otherwise healthy people and affects all age groups, but occurs more often in the elderly. 

MalaCards based summary: Syncope is related to sick sinus syndrome 1 and short qt syndrome 2. An important gene associated with Syncope is SLC6A2 (Solute Carrier Family 6 Member 2), and among its related pathways are TarBasePathway and Physiological and Pathological Hypertrophy of the Heart. Affiliated tissues include testes, heart and brain.

Wikipedia:71 Syncope may refer to one of the following: more...

Related Diseases for Syncope

About this section

Diseases related to Syncope via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 298)
idRelated DiseaseScoreTop Affiliating Genes
1sick sinus syndrome 131.1KCNH2, KCNQ1, SCN5A
2short qt syndrome 230.9KCNH2, KCNQ1, SCN5A
3atrial fibrillation, familial, 1030.6KCNH2, KCNQ1, SCN5A
4atrial fibrillation, familial, 329.5CALM1, CALM2, CALM3, KCNH2, KCNJ2, KCNQ1
5third-degree atrioventricular block29.4KCNH2, KCNQ1, SCN5A
6subclavian steal syndrome29.1CALM1, CALM2, CALM3
7syncope, familial vasovagal12.1
8ventricular extrasystoles with syncope, perodactyly, and robin sequence11.8
9ventricular extrasystoles with syncopal episodes - perodactyly - robin sequence11.8
10catecholaminergic polymorphic ventricular tachycardia11.5
11ventricular tachycardia, catecholaminergic polymorphic, 111.5
12ventricular tachycardia, catecholaminergic polymorphic, 211.4
13ventricular tachycardia, catecholaminergic polymorphic, 411.4
14jervell and lange-nielsen syndrome11.4
15fainting11.3
16orthostatic intolerance10.9
17brugada syndrome10.9
18wolff-parkinson-white syndrome10.9
19postural hypotension10.9
20progressive familial heart block, type ii10.7
21long qt syndrome 910.7
22sinoatrial node dysfunction and deafness10.7
23long qt syndrome-310.7
24heart block, progressive, type ia10.7
25dementia, lewy body10.7
26cardiac arrhythmia, ankyrin-b-related10.7
27long qt syndrome-1110.7
28long qt syndrome 210.7
29long qt syndrome 110.7
30long qt syndrome-1010.7
31long qt syndrome 1310.7
32sick sinus syndrome 310.7
33long qt syndrome 1210.7
34long qt syndrome 610.7
35long qt syndrome 510.7
36andersen syndrome10.7
37atrial fibrillation, familial, 610.5
38atrial standstill 210.5
39cardiomyopathy, hypertrophic, 2010.5
40hyperinsulinemic hypoglycemia, familial, 710.5
41atrial fibrillation, familial, 1110.5
42atrial standstill, digenic10.5
43cardiomyopathy, hypertrophic, 210.5
44cardiomyopathy, dilated, 1aa, with or without lvnc10.5
45long qt syndrome 1510.5
46cardiomyopathy, familial hypertrophic, 910.5
47cardiomyopathy, familial hypertrophic10.5
48cardiomyopathy, hypertrophic, 1310.5
49cardiomyopathy, hypertrophic, 810.5
50cardiomyopathy, hypertrophic, 1610.5

Graphical network of the top 20 diseases related to Syncope:



Diseases related to syncope

Symptoms & Phenotypes for Syncope

About this section

Drugs & Therapeutics for Syncope

About this section

Drugs for Syncope (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 235)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Ranolazineapproved, investigationalPhase 4, Phase 280142387-99-3, 95635-55-556959
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
HMS1922F16
HMS2090L09
HMS2093D21
I01-2008
I06-0160
KEG-1295
LS-187267
Latixa
Lopac0_001062
 
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
RANOLAZINE
RS-43285
RS-43285-003
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine Dihydrochloride
Ranolazine dihydrochloride
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
ranolazine
2
Amiodaroneapproved, investigationalPhase 4, Phase 31221951-25-32157
Synonyms:
(2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone
(2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone
(2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone
(2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
(2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine
1951-25-3
2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran
2-Butyl-3-[3,5-diiodo-4-(2-di
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone
2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
5-18-02-00353 (Beilstein Handbook Reference)
AB00053422
AC1L1D1R
AC1Q2VCU
ASTA Medica Brand of Amiodarone Hydrochloride
Alphapharm Brand of Amiodarone Hydrochloride
Amidorone
Aminodarone
Amio-Aqueous IV
Amiobeta
Amiodarex
Amiodarona
Amiodarona [INN-Spanish]
Amiodarone
Amiodarone (USAN/INN)
Amiodarone Base
Amiodarone HCL
Amiodarone Hydrochloride
Amiodarone [USAN:BAN:INN]
Amiodarons
Amiodaronum
Amiodaronum [INN-Latin]
Amiohexal
Amjodaronum
Ancar
Aratac
Armstrong Brand of Amiodarone Hydrochloride
Arycor
BIDD:GT0425
BIDD:PXR0146
BPBio1_000372
BRN 1271711
BSPBio_000338
BSPBio_001574
BSPBio_002580
Berenguer Infale Brand of Amiodarone Hydrochloride
Betapharm Brand of Amiodarone Hydrochloride
Bio1_000026
Bio1_000515
Bio1_001004
Bio2_000294
Bio2_000774
Braxan
C06823
C25H29I2NO3
CAS-19774-82-4
CBiol_001740
CHEBI:2663
CHEMBL633
CID2157
Corbionax
Cordarex
Cordarone
Cordarone Intravenous
D000638
D02910
DB01118
DivK1c_000079
EINECS 217-772-1
 
G Gam Brand of Amiodarone Hydrochloride
HMS1791O16
HMS1989O16
HMS2089C07
Hexal Brand of Amiodarone Hydrochloride
IDI1_000079
IDI1_034044
KBio1_000079
KBio2_000294
KBio2_000741
KBio2_002862
KBio2_003309
KBio2_005430
KBio2_005877
KBio3_000587
KBio3_000588
KBio3_001800
KBioGR_000294
KBioGR_001859
KBioSS_000294
KBioSS_000741
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl
Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI)
Kordaron
L 3428
L-3428
L001174
L3428
LS-87088
Labaz
Leurquin Brand of Amiodarone Hydrochloride
Lopac-A-8423
Lopac0_000122
MolPort-003-703-670
NCGC00015096-01
NCGC00015096-02
NCGC00015096-03
NCGC00015096-10
NCGC00024242-03
NCGC00024242-04
NCGC00024242-05
NCGC00024242-06
NCI60_041885
NINDS_000079
Ortacrone
Pacerone
Pharma Investi Brand of Amiodarone Hydrochloride
Prestwick0_000409
Prestwick1_000409
Prestwick2_000409
Prestwick3_000409
QTL1_000008
Rytmarone
SKF 33134-A
SKF 33134A
SPBio_001825
SPBio_002277
STK529812
STOCK1S-12240
Sanofi Winthrop Brand of Amiodarone Hydrochloride
Sedacoron
Sedacorone
Spectrum2_001813
Spectrum3_001050
Spectrum4_001190
Spectrum5_001533
Spectrum_000261
Tachydaron
UNII-N3RQ532IUT
UNM000001215003
Wyeth Brand of Amiodarone Hydrochloride
amiodarone
ethylaminoethoxy)benzoyl]benzofuran
nchembio.79-comp9
nchembio732-comp1
on
pms-Amiodarone
3
EpoprostenolapprovedPhase 45461849-14-7, 35121-78-95280427, 5282411
Synonyms:
(5E)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z)-5-[(4R,5R)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoate
(5Z,13E,15S)-6,9a-epoxy-11a,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoic acid
(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
(5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
(5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oate
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid
(Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
136626-78-3
35121-78-9
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
5-[5-hydroxy-4-(3-hydroxyoct-1-enyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid
6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
61849-14-7
63748-50-5
63859-31-4
AC1L18LX
AC1L3FZB
AC1NQX0K
AC1NR00P
AC1O51WG
AC1O5HI7
AR-1I7150
BIDD:GT0514
BRD-K64054020-001-02-7
BRN 1690090
BSPBio_001496
Bio2_000216
Bio2_000696
C01312
CHEBI:15552
CHEMBL1139
CHEMBL307845
CID114805
CID11969614
CID159
CID5280427
CID5282411
CID6434194
CID6450541
 
CID9864371
CID9975312
D00106
DB01240
Epoprostanol
Epoprostenol
Epoprostenol (TN)
Epoprostenol (USAN/INN)
Epoprostenol [USAN:INN]
Epoprostenolum
Epoprostenolum [INN-Latin]
Flolan
HMS1791K18
HMS1989K18
IDI1_033966
KB-IV-24
KBio2_000216
KBio2_002784
KBio2_005352
KBio3_000431
KBio3_000432
KBioGR_000216
KBioSS_000216
LMFA03010087
LS-125828
NCGC00161285-01
NCGC00161285-02
NCGC00161285-03
PDSP1_001721
PDSP2_001704
PG-I2
PGI(sub 2)
PGI2
PGX
Prostacyclin
Prostacyclin I2
Prostacycline
Prostacyclins
Prostaglandin I
Prostaglandin I(2)
Prostaglandin I2
Prostaglandin X
Prostaglandin x
Prostaglandins X
SMP2_000227
TRY 200
Try-200
U 53,217
U-53217
UNII-DCR9Z582X0
Vasocyclin
epoprostenol
prostacyclin
prostaglandin I2
4
Treprostinilapproved, investigationalPhase 49181846-19-754786, 6918140
Synonyms:
((1R,2R,3aS,9aS)-2-hydroxy-1-((3S)-3-hydroxyoctyl)-2,3,3a,4,9,9a-hexahydro-1H-cylopent(b)naphthalen-5-yl)oxy)acetate
(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid
({(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-yl}oxy)acetic acid
15 AU81
15AU81
2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
2-[[(1S,2S,3aR,9aR)-2-hydroxy-1-[(3R)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid
289480-64-4 (Sodium salt)
81846-19-7
AC1L1HPX
AC1OCF2J
CHEBI:50861
CID11246284
CID54786
CID6918140
CID9800580
D06213
DB00374
L001079
 
LRX 15
LS-177654
LS-187014
LS-187645
Remodulin (TN)
Treprostinil
Treprostinil (USAN/INN)
Treprostinil [USAN:INN]
Treprostinil sodium
Treprostinilo
Treprostinilum
U 62840
U-62,840
UNII-RUM6K67ESG
UT-15
Uniprost
Viveta
[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid
treprostinilo
treprostinilum
5
FludrocortisoneapprovedPhase 427127-31-131378
Synonyms:
(11beta)-9-Fluoro-11,17,21-trihydroxypregn-4-ene-3,20-dione
(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
127-31-1
4-08-00-03427 (Beilstein Handbook Reference)
9 .alpha. FF
9 Fluoro 17 Hydroxycortisone
9 Fluorocortisol
9 Fluorohydrocortisone
9 alpha FF
9 alpha Fludrohydrocortisone
9 alpha Fluoro 17 Hydroxycorticosterone
9 alpha Fluorohydrocortisone
9 alpha-Fludrocortisone
9 alpha-Fluoro-17-Hydroxycorticosterone
9 alpha-Fluorocortisol
9 alpha-Fluorohydrocortisone
9-AF
9-AFH
9-Fluoro-11-beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione
9-Fluoro-17-Hydroxycortisone
9-Fluorocortisol
9-Fluorohydrocortisone
9-alpha-Fludrocortisone
9-alpha-Fluoro-17-hydroxycorticosterone
9-alpha-Fluorocortisol
9-alpha-Fluorohydrocortisone
9.alpha.-Fluoro-11.beta.,17.alpha.,21-trihydroxy-4-pregnene-3,20-dione
9.alpha.-Fluoro-17-hydroxycorticosterone
9.alpha.-Fluorocortisol
9.alpha.-Fluorohydrocortisone
9alpha-FLUOROCORTISOL
9alpha-Fludrocortisone
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-4-pregnene-3,20-dione
9alpha-Fluoro-17-hydroxycorticosterone
9alpha-Fluoro-hydrocortisone
9alpha-Fluorocortisol
AC1L1LI8
AC1Q5HJH
Alflorone
Astonin
Astonin H
Astonin Merck
Astonin-H
Astonin-H (TN)
BRN 3014278
 
C07004
C21H29FO5
CHEBI:50885
CHEMBL1201388
CID31378
D005438
D07967
DB00687
DB02478
EINECS 204-833-2
F-COL
F-Cortef
FCOL
Florinef
Fludrocortison
Fludrocortisona
Fludrocortisona [INN-Spanish]
Fludrocortisone
Fludrocortisone (INN)
Fludrocortisone [INN:BAN]
Fludrocortisonum
Fludrocortisonum [INN-Latin]
Fludrocortone
Fludrone
Fludronef
Fluodrocortisone
Fluohydrisone
Fluohydrocortisone
Fluorocortisol
Fluorocortisone
HSDB 3332
Hydrocortisone-9alpha-fluoro
LMST02030103
LS-118690
Merck Brand of Fludrocortisone
Merck, Astonin
MolPort-005-943-437
NCGC00181081-01
NSC 11318
NSC11318
Pregn-4-ene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy- (8CI)
Prestwick_648
StC 1400
U 5963
UNII-U0476M545B
WLN: L E5 B666 OV MUTJ A1 BF CQ E1 FV1Q FQ
ZINC04097304
ZK5
fludrocortisone
6
Propranololapproved, investigationalPhase 4, Phase 2228525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
7
MidodrineapprovedPhase 447133163-28-7, 42794-76-34195
Synonyms:
( -)-Midodrin hydrochloride
( -)-Midodrine hydrochloride
()-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(+-)-1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
(+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide monohydrochloride
(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide
(+-)-Midodrine hydrochloride
(+/-)-1-(2,5-Dimethoxyphenyl)-2-glycinamidoethanol
(RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol
1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol hydrochloride
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide
2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide monohydrochloride
2-Amino-N-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide monohydrochloride
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide
2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide hydrochloride
3092-17-9
3092-17-9 (mono-hydrochloride)
42794-76-3
42794-76-3 (Parent)
43218-56-0
97476-58-9
A 4020 Linz
A-4020 Linz
AB00053715
AC1L1HMJ
AC1L2BU9
Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, monohydrochloride
Acetamide, 2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)-, hydrochloride
Alphamine
Amatine
BPBio1_000157
BRD-A79981887-003-05-7
BSPBio_000141
BSPBio_003150
C07890
C12H18N2O4
C12H18N2O4.HCl
CHEBI:31847
CHEBI:6933
CHEMBL1200461
CID18340
CID4195
CPD000058833
D01307
D08220
DB00211
DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid
DivK1c_000955
EINECS 255-945-3
EINECS 256-148-3
Gutron
HMS1568H03
HMS1922O03
Hipertan
I06-0865
IDI1_000955
KBio1_000955
KBio2_002121
KBio2_004689
KBio2_007257
 
KBio3_002650
KBioGR_000763
KBioSS_002121
LS-174957
LS-8042
LS-8052
M8277_FLUKA
M8277_SIGMA
MIDODRINE HYDROCHLORIDE
MLS001332567
MLS001332568
MLS002154233
Metligene
Midamine
Midodrin
Midodrina
Midodrina [INN-Spanish]
Midodrine (INN)
Midodrine HCL
Midodrine Monohydrochloride
Midodrine [BAN:INN]
Midodrine [INN:BAN]
Midodrine hydrochloride
Midodrine hydrochloride (JAN/USAN)
Midodrine hydrochloride [USAN:JAN]
Midodrine hydrochloride [USAN]
Midodrinum
Midodrinum [INN-Latin]
MolPort-003-666-473
MolPort-003-849-221
N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide
N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide
NCGC00095311-01
NCGC00178238-01
NCGC00178238-02
NINDS_000955
Prestwick0_000191
Prestwick1_000191
Prestwick2_000191
Prestwick3_000191
Prestwick_625
Pro-Amatine
Pro-Amatine (TN)
ProAmatine
SAM002564219
SBB066174
SMR000058833
SPBio_001390
SPBio_002062
SPECTRUM1503257
ST-1085
Spectrum2_001545
Spectrum3_001585
Spectrum4_000192
Spectrum5_000962
Spectrum_001641
St 1085
St. Peter 224
TL8002369
TS 701
UNII-59JV96YTXV
UNII-6YE7PBM15H
[+/-]-1-[2,5-Dimethoxyphenyl]-2-glycinamidoethanol
midodrine
8
AmlodipineapprovedPhase 449688150-42-92162
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC-4535
AC1L1D26
AC1Q32ZS
AMLODIPINE BASE
AMVAZ
Ambap88150-42-9
Amlocard
Amlodipine
Amlodipine (INN)
Amlodipine Benzenesulfonate
Amlodipine Besilate
Amlodipine Besylate
Amlodipine Free Base
Amlodipine [INN:BAN]
Amlodipine besilate
Amlodipine besylate
Amlodipine free base
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
 
Amvaz
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
CPD000469198
Coroval
D07450
DB00381
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
LS-131183
Lipinox
Lotrel
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
R,S)-Amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
amlodipine
9
Hydrochlorothiazideapproved, vet_approvedPhase 4, Phase 341358-93-53639
Synonyms:
125727-50-6
3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothi
3,4-Dihydrochlorothiazide
58-93-5
6-Chloro-7-sulfamoyl-3, 4-dihy
8049-49-8
AB00052012
AC-11072
AC1L1GDT
AC1Q55FM
AF-614/30832002
AKOS000121373
ARONIS24316
Acesistem
Acuilix
Acuretic
Aldactazide
Aldactazide 25/25
Aldazida
Aldectazide 50/50
Aldoril
Ambap58-93-5
Apo-Hydro
Apresazide
Aquarills
Aquarius
Aquazide H
Aquazide-H
BAS 00371709
BIDD:GT0153
BPBio1_000019
BRD-K13078532-001-05-2
BRN 0625101
BSPBio_000017
BSPBio_002132
Bio-0714
Bremil
Briazide
C7H8ClN3O4S2
CAS-58-93-5
CCRIS 2082
CHEMBL435
CID3639
CPD000035778
Caplaril
Capozide
Carozide
Catiazida
Chlorizide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Chlothia
Cidrex
Clorana
Component of Butizide Prestabs
Concor Plus
Condiuren
D00340
D006852
DB00999
Diaqua
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Didral
Dihydran
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Disothiazid
Diu 25 Vigt
Diu-Melusin
Diu-melusin
Diuril
Diurogen
DivK1c_000289
Dixidrasi
Drenol
Dyazide
EINECS 200-403-3
EU-0100614
Esidrex
Esidrix
Esidrix (TN)
Esimil
Esoidrina
FT-0082750
Fluvin
H 4759
H1274
H2910_SIAL
H4759_SIAL
HCT
HCT-Isis
HCTZ
HCZ
HMS1568A19
HMS1920D19
HMS2091L05
HMS500O11
HMS553N04
HSDB 3096
Hidril
Hidro-Niagrin
Hidrochlortiazid
Hidroclorotiazida
Hidroclorotiazida [INN-Spanish]
Hidroronol
Hidrosaluretil
Hidrotiazida
Hyclosid
Hydrex-semi
Hydril
Hydro Par
Hydro-Aquil
Hydro-D
Hydro-Diuril
Hydro-Saluric
Hydro-T
Hydro-chlor
HydroDIURIL
Hydrochlorat
Hydrochloro Thiazide
Hydrochlorot
Hydrochlorothiazid
Hydrochlorothiazide
Hydrochlorothiazide (JP15/USP/INN)
Hydrochlorothiazide Intensol
Hydrochlorothiazide [INN:BAN:JAN]
 
Hydrochlorothiazidum
Hydrochlorothiazidum [INN-Latin]
Hydrochlorthiazide
Hydrochlorthiazidum
Hydrocot
Hydrodiuretic
Hydrodiuril
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hydrozide Injection, Veterinary
Hypothiazid
Hypothiazide
Hytrid
Hyzaar
I09-0531
IDI1_000289
Idroclorotiazide
Idroclorotiazide [DCIT]
Idrotiazide
Inderide
Inderide 80/25
Indroclor
Ivaugan
Jen-Diril
KBio1_000289
KBio2_001357
KBio2_003925
KBio2_006493
KBio3_001352
KBioGR_000351
KBioSS_001357
LS-243
Lopac-H-4759
Lopac0_000614
Lopressor HCT
Lotensin HCT
Lotensin Hct
MLS000069619
Manuril
Maschitt
Maxzide
Maybridge Compound 10
Maybridge1_004336
Mazide 25 mg
Medozide
Megadiuril
Microzide
Microzide (TN)
Mictrin
Mikorten
Modurcen
Moduretic
MolPort-000-144-465
NCGC00015508-01
NCGC00015508-02
NCGC00015508-03
NCGC00015508-07
NCGC00015508-12
NCGC00021906-03
NCGC00021906-04
NCGC00021906-05
NCGC00021906-06
NCGC00021906-07
NCGC00021906-08
NCI-C55925
NCI60_004317
NINDS_000289
NSC 53477
NSC53477
Natrinax
Nefrix
Nefrol
Neo-Codema
Neo-Flumen
Neo-Minzil
Neo-codema
Neoflumen
Newtolide
Novodiurex
Oprea1_357174
Oretic
Pantemon
Panurin
Prestwick0_000009
Prestwick1_000009
Prestwick2_000009
Prestwick3_000009
Prestwick_263
Prinzide
Raunova Plus
Ro-Hydrazide
Ro-hydrazide
Roxane
S1708_Selleck
SAM002554901
SMR000035778
SPBio_001259
SPBio_001938
SPECTRUM1500335
STK315354
Saldiuril
Sectrazide
Selozide
Ser-Ap-Es
Servithiazid
Spectrum2_001040
Spectrum3_000456
Spectrum4_000006
Spectrum5_000824
Spectrum_000877
Spironazide
Su 5879
Tandiur
Thiaretic
Thiuretic
Thlaretic
Timolide
UNII-0J48LPH2TH
Unazid
Unipres
Urodiazin
Urozide
Vaseretic
Vetidrex
WLN: T66 BSWM EM DHJ HG ISZW
ZINC00896569
Ziac
Zide
adiazine-1,1-dioxide
component of Aldactazide
component of Aldoril
component of Caplaril
component of Cyclex
component of Dyazide
component of Esimil
diclot ride
dro-2H-1,2,4-benzothiadiazine 1,1-dioxide
hydrochlorothiazide
panurin dichloride
10
LosartanapprovedPhase 4286114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
11
MethyltestosteroneapprovedPhase 456358-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
12
Testosteroneapproved, investigationalPhase 456358-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
13
Metoprololapproved, investigationalPhase 421237350-58-6, 51384-51-14171
Synonyms:
(+/-)-Metoprolol
(RS)-Metoprolol
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol
1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol
3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol
37350-58-6
51384-51-1
54163-88-1
AB00053499
AC-19022
AC1L1HKM
AstraZeneca Brand of Metaoprolol Tartrate
AstraZeneca Brand of Seloken
BRD-A03623303-045-02-0
Beatrolol
Beloc
Beloc Duriles
Beloc-Duriles
BelocDuriles
Betaloc
Betaloc Astra
Betaloc-Astra
BetalocAstra
Betalok
C07202
CCRIS 4198
CGP 2175
CGP-2175
CGP2175
CHEBI:6904
CHEMBL13
CID4171
D008790
D02358
DB00264
DL-metoprolol
Dl-Metoprolol
Dutoprol
EINECS 253-483-7
EINECS 257-166-4
H 93 26
H 93-26
H 9326
 
HMS2090B15
HSDB 6531
I01-7125
I06-0125
Jsp006606
L000669
LOPRESSIDONE
LS-122450
Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate
Lopresor
Lopresoretic
Lopressor
Lopressor HCT
Meijoprolol
Metohexal
Metoprolol
Metoprolol (USAN/INN)
Metoprolol Tartrate
Metoprolol [USAN:INN:BAN]
Metoprolol slow release
Metoprolol succinate
Metoprolol tartrate
Metoprololum
Metoprololum [INN-Latin]
Metroprolol
MolPort-005-938-039
NCGC00021148-02
NCGC00021148-03
NCGC00021148-04
Novartis Brand of Metprolol Tartrate
Preblok
Prelis
Presolol
Selo-Zok
Seloken
Seloken AstraZeneca Brand
Selopral
Seroken
Spesicor
Spesikor
TOPROL-XL
Tartrate, Metoprolol
Toprol
Toprol XL
Toprol-XL
UNII-GEB06NHM23
dl-Metoprolol
metoprolol
14
DonepezilapprovedPhase 4286120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
15Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 123689
16Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 118340
17Cytochrome P-450 CYP3A InhibitorsPhase 4, Phase 31715
18Diuretics, Potassium SparingPhase 4, Phase 3, Phase 21917
19Cytochrome P-450 CYP2D6 InhibitorsPhase 4, Phase 3727
20Cytochrome P-450 CYP2C9 InhibitorsPhase 4, Phase 3669
21Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 23093
22Cytochrome P-450 CYP1A2 InhibitorsPhase 4, Phase 3572
23Potassium Channel BlockersPhase 4, Phase 3180
24Cytochrome P-450 Enzyme InhibitorsPhase 4, Phase 33917
25Anti-Inflammatory AgentsPhase 4, Phase 1, Phase 210729
26Sodium Channel BlockersPhase 4, Phase 3, Phase 21593
27Vasodilator AgentsPhase 4, Phase 3, Phase 23543
28AndrogensPhase 41321
29Adrenergic beta-1 Receptor AntagonistsPhase 4, Phase 3364
30Hormone AntagonistsPhase 413180
31Antineoplastic Agents, HormonalPhase 45592
32HormonesPhase 4, Phase 1, Phase 214415
33Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 413168
34TezosentanPhase 464
35Testosterone 17 beta-cypionatePhase 4563
36SympatholyticsPhase 4, Phase 3580
37Testosterone undecanoatePhase 4563
38
Testosterone enanthatePhase 4563315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
39Angiotensin II Type 1 Receptor BlockersPhase 4, Phase 31091
40Adrenergic AgonistsPhase 4, Phase 1, Phase 2, Early Phase 13027
41Adrenergic alpha-AgonistsPhase 4, Phase 1, Phase 2, Early Phase 11734
42Autonomic AgentsPhase 4, Phase 3, Phase 1, Phase 2, Early Phase 110150
43Antihypertensive AgentsPhase 4, Phase 3, Phase 24207
44Adrenergic beta-AntagonistsPhase 4, Phase 3, Phase 2, Phase 11193
45Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15352
46Adrenergic AntagonistsPhase 4, Phase 3, Phase 21573
47Vasoconstrictor AgentsPhase 4, Phase 1, Phase 2, Early Phase 12122
48
Angiotensin IIPhase 4, Phase 3117868521-88-0, 11128-99-765143, 172198
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
49diureticsPhase 4, Phase 3, Phase 1, Phase 21418
50Natriuretic AgentsPhase 4, Phase 3, Phase 1, Phase 21697

Interventional clinical trials:

(show top 50)    (show all 282)
idNameStatusNCT IDPhase
1Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)Unknown statusNCT01621464Phase 4
2Safety of Amiodarone and Ranolazine Together in Patients With AnginaUnknown statusNCT01558830Phase 4
3ISSUE3: International Study on Syncope of Uncertain Etiology 3CompletedNCT00359203Phase 4
4Clinical Trial for the Prevention of Vasovagal SyncopeCompletedNCT00118482Phase 4
5ELIAS: Early Loop-Recorder in Suspected Arrhythmogenic SyncopeCompletedNCT00170261Phase 4
6Propranolol to Treat Fainting Due to Sympathoadrenal ImbalanceCompletedNCT00060866Phase 4
7Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCompletedNCT01518946Phase 4
8Comparision of Blood Pressure Variability Between Amlodipine and LosartanCompletedNCT01964079Phase 4
9Multicenter Automatic Defibrillator Implantation Trial - Reduce Inappropriate TherapyCompletedNCT00947310Phase 4
10Programming Implantable Cardioverter Defibrillators in Patients With Primary Prevention IndicationCompletedNCT00743522Phase 4
11Physiologic Evaluation of Anomalous Right Coronary Artery StenosisCompletedNCT01133054Phase 4
12Effects of Testosterone on Myocardial RepolarizationCompletedNCT03126656Phase 4
13A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy SitesCompletedNCT01722994Phase 4
14Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to RemodulinCompletedNCT00373360Phase 4
15Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IVRecruitingNCT01456481Phase 4
16Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging SubjectsRecruitingNCT02123056Phase 4
17Combining Donepezil With Perceptual Learning in Normal and Amblyopic Human AdultsRecruitingNCT03109314Phase 4
18Evaluation of PCLs Using Three EUS-FNA NeedlesRecruitingNCT01711294Phase 4
19Syncope: Pacing or Recording in the Later YearsActive, not recruitingNCT01423994Phase 4
20International Study on Syncope of Uncertain EtiologyTerminatedNCT00120094Phase 4
21A Phase IV Study in Subjects With Neurogenic Orthostatic HypotensionTerminatedNCT00046163Phase 4
22Rapid Switch From Flolan to Remodulin in the Outpatient ClinicTerminatedNCT00643604Phase 4
23Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAHTerminatedNCT00439946Phase 4
24Adenosine Testing to DEtermine the Need for Pacing TherapyUnknown statusNCT01481168Phase 3
25Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in ChildrenUnknown statusNCT01587846Phase 3
26Stop Vasodepressor Drugs in Reflex SyncopeCompletedNCT02137278Phase 3
27A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3
28Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate HypertensionCompletedNCT00095550Phase 3
29Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionCompletedNCT00095394Phase 3
30Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3
31Ablation of Clinical Ventricular Tachycardia Versus Addition of Substrate Ablation on the Long Term Success Rate of VT AblationCompletedNCT01045668Phase 3
32Cooperative Studies Program #563 - Prazosin and Combat Trauma PTSDCompletedNCT00532493Phase 3
33Induction With Foley OR Misoprostol (INFORM) StudyCompletedNCT01801410Phase 3
34Chagas Cardiomyopathy Bisoprolol Intervention Study: CharityCompletedNCT00323973Phase 3
35Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of LaborCompletedNCT00308711Phase 3
36A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3
37Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3
38Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory SyncopeRecruitingNCT01814228Phase 3
39Perioperative Antibiotic Therapy to Prevent Cardiac Implantable Electronic Device Infections.RecruitingNCT02809131Phase 3
40Efficacy of Implantable Defibrillator Therapy After a Myocardial InfarctionRecruitingNCT00673842Phase 3
41Effects of PTH Replacement on Bone in HypoparathyroidismActive, not recruitingNCT00395538Phase 3
42Ballooned Intercostal Drain TrialNot yet recruitingNCT03000504Phase 3
43Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained SyncopeTerminatedNCT00143754Phase 3
44A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3
45Hydroquinidine Versus Placebo in Patients With Brugada SyndromeTerminatedNCT00927732Phase 3
46Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave LithotripsyWithdrawnNCT01560091Phase 3
47Evaluate the Noninferiority of Medicines Treating Uninfected Pressure Ulcers.WithdrawnNCT02004626Phase 3
48Trial Comparing Ablation With Medical Therapy in Patients With Ventricular TachycardiaWithdrawnNCT01798277Phase 3
49ASIS for Enbrel in Plaque PsoriasisUnknown statusNCT02112097Phase 1, Phase 2
50Non-Pharmacologic Therapy for Neurocardiogenic SyncopeCompletedNCT00096902Phase 2

Search NIH Clinical Center for Syncope

Genetic Tests for Syncope

About this section

Genetic tests related to Syncope:

id Genetic test Affiliating Genes
1 Syncope27

Anatomical Context for Syncope

About this section

MalaCards organs/tissues related to Syncope:

36
Testes, Heart, Brain, Skin, Temporal lobe, Tongue, Lung

Publications for Syncope

About this section

Articles related to Syncope:

(show top 50)    (show all 884)
idTitleAuthorsYear
1
The effects of body weight status on orthostatic intolerance and predisposition to noncardiac syncope. (28112481)
2017
2
Post-exercise syncope: Wingate syncope test and visual-cognitive function. (27550986)
2016
3
Searching for the cause of syncope: non-sustained ventricular tachycardia or neurocardiogenic syndrome. Does it really need lengthy investigation? (27098073)
2016
4
A rare cause of syncope in a young female. (27567040)
2016
5
The mechanism of syncope without prodromes with normal heart and normal electrocardiogram. (27639455)
2016
6
Syncope and sudden cardiac death: some answers to clinical challenges. (27190173)
2016
7
Syncope in a 62-year-old man with sarcoidosis. (27131072)
2016
8
Intracardiac Leiomyomatosis - an Unusual Cause of Syncope in a Middle-Aged Woman. (27743856)
2016
9
Syncope and collapse in acute pulmonary embolism. (27107684)
2016
10
Differential effects of ganglionic plexi ablation in a patient with neurally mediated syncope and intermittent atrioventricular block: a commentary. (27302390)
2016
11
Long-Term Outcome of Patients with Bifascicular Block and Unexplained Syncope Following Cardiac Pacing. (27565449)
2016
12
The circadian rhythm of syncopal episodes in patients with neurally mediated syncope. (27128529)
2016
13
Type I Chiari malformation presenting orthostatic syncope who treated with decompressive surgery. (28018469)
2016
14
Syncope in older adults. (27594863)
2016
15
Thrombosis of Inferior Vena Cava Diagnosed Using Point-of-Care Ultrasound After Pediatric Near-Syncope. (27545854)
2016
16
From syncope episode to the diagnosis of ovarian dermoid cyst associated with a cystadenoma. (26968295)
2016
17
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. (27092427)
2016
18
The Evaluation of Syncope in a Predominantly Black Population: Focus on Neuroimaging. (27583235)
2016
19
Theophylline and syncope. (27537745)
2016
20
Primary Cardiac Sarcoidosis with Syncope and Refractory Atrial Arrhythmia: A Case Report and Review of the Literature. (27303240)
2016
21
Short term prognosis and current management of syncopal patients at intermediate-risk. Results from the IRiS (Intermediate-Risk Syncope) Study. (27178670)
2016
22
Management of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia and Vasovagal Syncope. (27617091)
2016
23
Case 4 - A 67 Year-Old Man with Aortic Regurgitation Who Presented Syncope Followed by Shock. (27627642)
2016
24
Accessory Liver in the Right Atrium: A Rare Cause of Syncope. (27549551)
2016
25
Syncope (Fainting). (27142609)
2016
26
Syncope in an Athlete: a Case of Infectious Mononucleosis-Induced Postural Tachycardia Syndrome. (26745170)
2016
27
Pathophysiological mechanisms of noncardiac syncope in athletes. (27606909)
2016
28
Syncope on a Hot Summer Day. (27131612)
2016
29
Syncope in patients paced for atrioventricular block. (26851815)
2016
30
Beta 3 subunit of G-protein and its influence on autonomic nervous system in patients with vasovagal syncope. (26925743)
2016
31
Recurrent Syncope: An Unusual Complication of Hypertensive Heart Disease. (27448490)
2016
32
Straight Back Syndrome Masquerading as a Mass, with Near-Syncope. (27127446)
2016
33
Stop vasodepressor drugs in reflex syncope: a randomised controlled trial. (27664002)
2016
34
Assessment of endothelin and copeptin as biomarkers for vasovagal syncope. (26641207)
2016
35
Chronic Myeloid Leukemia: A Case of Extreme Thrombocytosis Causing Syncope and Myocardial Infarction. (27004153)
2016
36
Syncope Following Orthotopic Heart Transplant: Sinoatrial or Atrioventricular Nodal Block? (27214093)
2016
37
Genome-Wide Association Study of Copy Number Variations in Patients with Familial Neurocardiogenic Syncope. (27156083)
2016
38
Differential effect of ganglionic plexi ablation in a patient with neurally mediated syncope and intermittent atrioventricular block. (27194540)
2016
39
77-year-old female with syncope. (27664004)
2016
40
Reduced compensatory responses to maintain central blood volume during hypovolemic stress in women with vasovagal syncope. (27654398)
2016
41
The Cost-Effective Evaluation of Syncope. (27542422)
2016
42
Inflammatory myofibroblastic tumor of carotid artery resulting in recurrent syncope: A case report. (27028414)
2016
43
The Current Indication for Pacemaker in Patients with Cardioinhibitory Vasovagal Syncope. (27651841)
2016
44
Self-controllable prodromal symptoms of syncope attributed to carotid sinus syndrome during the end stage of cancer: a case report. (27602053)
2016
45
Syncope: Not for the faint hearted. (27189260)
2016
46
A Male Patient with Syncope, Anaphylaxis, and ST-Elevation: Hepatic and Cardiac Echinococcosis Presenting with Kounis Syndrome. (27516403)
2016
47
Opportunities for Emergency Medical Services (EMS) Care of Syncope. (27211803)
2016
48
Heartbeat: Detection of arrhythmias in older adults with falls and syncope. (27073247)
2016
49
What factors influence parents' perception of the quality of life of children and adolescents with neurocardiogenic syncope? (27188269)
2016
50
Gene Polymorphism of the Adenosine A2a Receptor in Patients with Vasovagal Syncope. (26710963)
2016

Variations for Syncope

About this section

Expression for genes affiliated with Syncope

About this section
Search GEO for disease gene expression data for Syncope.

Pathways for genes affiliated with Syncope

About this section

Pathways related to Syncope according to GeneCards Suite gene sharing:

(show top 50)    (show all 90)
idSuper pathwaysScoreTop Affiliating Genes
19.6KCNJ2, KCNQ1
29.1CALM1, CALM2
39.1CALM1, CALM2
49.1CALM1, CALM2
59.1CALM1, CALM2
69.1CALM1, CALM2
79.0GNB3, KCNH2, KCNQ1, SCN5A
88.9KCNH2, KCNJ2, KCNQ1, SCN5A
9
Show member pathways
8.9GNB3, KCNH2, KCNJ2, KCNQ1
10
Show member pathways
8.7CALM1, CALM2, NPPA
11
Show member pathways
8.5CALM1, CALM2, CALM3
12
Show member pathways
8.5CALM1, CALM2, CALM3
13
Show member pathways
8.5CALM1, CALM2, CALM3
14
Show member pathways
8.5CALM1, CALM2, CALM3
15
Show member pathways
8.5CALM1, CALM2, CALM3
16
Show member pathways
8.5CALM1, CALM2, CALM3
178.5CALM1, CALM2, CALM3
188.5CALM1, CALM2, CALM3
19
Show member pathways
8.5CALM1, CALM2, CALM3
208.5CALM1, CALM2, CALM3
218.5CALM1, CALM2, CALM3
22
Show member pathways
8.5CALM1, CALM2, CALM3
238.5CALM1, CALM2, CALM3
248.5CALM1, CALM2, CALM3
258.5CALM1, CALM2, CALM3
26
Show member pathways
8.5CALM1, CALM2, CALM3
27
Show member pathways
8.5CALM1, CALM2, CALM3
28
Show member pathways
8.5CALM1, CALM2, CALM3
29
Show member pathways
8.5CALM1, CALM2, CALM3
308.5CALM1, CALM2, CALM3
31
Show member pathways
8.5CALM1, CALM2, CALM3
32
Show member pathways
8.5CALM1, CALM2, CALM3
33
Show member pathways
8.5CALM1, CALM2, CALM3
348.5CALM1, CALM2, CALM3
358.5CALM1, CALM2, CALM3
368.5CALM1, CALM2, CALM3
37
Show member pathways
8.5CALM1, CALM2, CALM3
388.5CALM1, CALM2, CALM3
39
Show member pathways
8.5CALM1, CALM2, CALM3
408.5CALM1, CALM2, CALM3
418.5CALM1, CALM2, CALM3
42
Show member pathways
8.5CALM1, CALM2, CALM3
43
Show member pathways
8.5CALM1, CALM2, CALM3
44
Show member pathways
8.5CALM1, CALM2, CALM3
45
Show member pathways
8.5CALM1, CALM2, CALM3
46
Show member pathways
8.5CALM1, CALM2, CALM3
478.5CALM1, CALM2, CALM3
48
Show member pathways
8.5CALM1, CALM2, CALM3
498.5CALM1, CALM2, CALM3
50
Show member pathways
8.5CALM1, CALM2, CALM3

GO Terms for genes affiliated with Syncope

About this section

Cellular components related to Syncope according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1T-tubuleGO:003031510.2KCNJ2, SCN5A
2calcium channel complexGO:00347049.3CALM1, CALM2, CALM3
3voltage-gated potassium channel complexGO:00080769.3KCNH2, KCNJ2, KCNQ1
4sarcomereGO:00300179.2CALM1, CALM2, CALM3
5spindleGO:00058199.2CALM1, CALM2, CALM3
6spindle microtubuleGO:00058769.2CALM1, CALM2, CALM3
7spindle poleGO:00009229.1CALM1, CALM2, CALM3
8vesicleGO:00319829.0CALM1, CALM2, CALM3
9plasma membraneGO:00058866.9CALM1, CALM2, CALM3, GNB3, KCNH2, KCNJ2

Biological processes related to Syncope according to GeneCards Suite gene sharing:

(show top 50)    (show all 55)
idNameGO IDScoreTop Affiliating Genes
1membrane repolarization during ventricular cardiac muscle cell action potentialGO:009891510.5KCNH2, KCNQ1
2potassium ion exportGO:007143510.5KCNH2, KCNQ1
3potassium ion export across plasma membraneGO:009762310.5KCNH2, KCNQ1
4atrial cardiac muscle cell action potentialGO:008601410.5KCNQ1, SCN5A
5membrane depolarization during action potentialGO:008601010.5KCNH2, SCN5A
6positive regulation of cardiac muscle contractionGO:006045210.4KCNQ1, NPPA
7positive regulation of heart rateGO:001046010.4KCNQ1, NPPA
8cardiac muscle cell action potential involved in contractionGO:008600210.3KCNJ2, SCN5A
9membrane depolarization during cardiac muscle cell action potentialGO:008601210.3KCNJ2, SCN5A
10regulation of cardiac muscle cell contractionGO:008600410.3KCNJ2, SCN5A
11cardiac muscle contractionGO:006004810.2KCNH2, KCNQ1, SCN5A
12regulation of ventricular cardiac muscle cell membrane repolarizationGO:006030710.1KCNH2, KCNQ1, SCN5A
13membrane repolarization during action potentialGO:008601110.0KCNH2, KCNJ2, KCNQ1
14membrane repolarization during cardiac muscle cell action potentialGO:008601310.0KCNH2, KCNJ2, KCNQ1
15positive regulation of potassium ion transmembrane transportGO:190138110.0KCNH2, KCNJ2, KCNQ1
16regulation of atrial cardiac muscle cell membrane repolarizationGO:006037210.0KCNQ1, NPPA, SCN5A
17potassium ion transmembrane transportGO:007180510.0KCNH2, KCNJ2, KCNQ1
18potassium ion transportGO:000681310.0KCNH2, KCNJ2, KCNQ1
19regulation of membrane repolarizationGO:006030610.0KCNH2, KCNJ2, KCNQ1
20regulation of high voltage-gated calcium channel activityGO:19018419.9CALM1, NPPA
21ventricular cardiac muscle cell action potentialGO:00860059.9KCNH2, KCNQ1, SCN5A
22cardiac conductionGO:00613379.7KCNH2, KCNJ2, KCNQ1, SCN5A
23ion transportGO:00068119.7KCNH2, KCNJ2, KCNQ1, SCN5A
24regulation of heart rate by cardiac conductionGO:00860919.6KCNH2, KCNJ2, KCNQ1, SCN5A
25regulation of ion transmembrane transportGO:00347659.6KCNH2, KCNJ2, KCNQ1, SCN5A
26transmembrane transportGO:00550859.6KCNH2, KCNQ1, SCN5A, SLC6A2
27detection of calcium ionGO:00055139.3CALM1, CALM2, CALM3
28Fc-epsilon receptor signaling pathwayGO:00380959.3CALM1, CALM2, CALM3
29glycogen catabolic processGO:00059809.3CALM1, CALM2, CALM3
30inositol phosphate metabolic processGO:00436479.3CALM1, CALM2, CALM3
31muscle contractionGO:00069369.2CALM1, CALM2, CALM3
32negative regulation of peptidyl-threonine phosphorylationGO:00108019.2CALM1, CALM2, CALM3
33negative regulation of ryanodine-sensitive calcium-release channel activityGO:00603159.2CALM1, CALM2, CALM3
34platelet degranulationGO:00025769.2CALM1, CALM2, CALM3
35positive regulation of cyclic nucleotide metabolic processGO:00308019.2CALM1, CALM2, CALM3
36positive regulation of cyclic-nucleotide phosphodiesterase activityGO:00513439.2CALM1, CALM2, CALM3
37positive regulation of peptidyl-threonine phosphorylationGO:00108009.2CALM1, CALM2, CALM3
38positive regulation of phosphoprotein phosphatase activityGO:00325169.2CALM1, CALM2, CALM3
39positive regulation of protein autophosphorylationGO:00319549.2CALM1, CALM2, CALM3
40positive regulation of protein dephosphorylationGO:00353079.2CALM1, CALM2, CALM3
41positive regulation of protein serine/threonine kinase activityGO:00719029.2CALM1, CALM2, CALM3
42positive regulation of ryanodine-sensitive calcium-release channel activityGO:00603169.2CALM1, CALM2, CALM3
43protein methylationGO:00064799.2CALM1, CALM2, CALM3
44regulation of cardiac muscle contractionGO:00551179.2CALM1, CALM2, CALM3
45regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ionGO:00108819.2CALM1, CALM2, CALM3
46regulation of cell communication by electrical coupling involved in cardiac conductionGO:19018449.2CALM1, CALM2, CALM3
47regulation of cytokinesisGO:00324659.2CALM1, CALM2, CALM3
48regulation of nitric-oxide synthase activityGO:00509999.2CALM1, CALM2, CALM3
49regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulumGO:00108809.2CALM1, CALM2, CALM3
50regulation of rhodopsin mediated signaling pathwayGO:00224009.2CALM1, CALM2, CALM3

Molecular functions related to Syncope according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1delayed rectifier potassium channel activityGO:000525110.5KCNH2, KCNQ1
2inward rectifier potassium channel activityGO:000524210.3KCNH2, KCNJ2
3scaffold protein bindingGO:009711010.0KCNH2, KCNQ1, SCN5A
4nitric-oxide synthase bindingGO:005099810.0CALM1, SCN5A
5voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationGO:19022829.8KCNH2, KCNQ1
6voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationGO:00860089.5KCNH2, KCNJ2, KCNQ1
7inositol-1,4,5-trisphosphate 3-kinase activityGO:00084409.2CALM1, CALM2, CALM3
8voltage-gated ion channel activityGO:00052449.2KCNH2, KCNJ2, KCNQ1, SCN5A
9ligand-gated ion channel activityGO:00152769.2CALM1, CALM2, CALM3
10N-terminal myristoylation domain bindingGO:00319979.2CALM1, CALM2, CALM3
11phospholipase bindingGO:00432749.2CALM1, CALM2, CALM3
12protein phosphatase activator activityGO:00725429.1CALM1, CALM2, CALM3
13protein serine/threonine kinase activator activityGO:00435399.1CALM1, CALM2, CALM3
14Ras guanyl-nucleotide exchange factor activityGO:00050889.1CALM1, CALM2, CALM3
15thioesterase bindingGO:00319969.1CALM1, CALM2, CALM3
16titin bindingGO:00314329.1CALM1, CALM2, CALM3
17protein domain specific bindingGO:00199048.8CALM1, CALM2, CALM3, SCN5A
18protein kinase bindingGO:00199018.8CALM1, CALM2, CALM3, SCN5A
19ion channel bindingGO:00443258.5CALM1, CALM2, CALM3, KCNQ1, SCN5A

Sources for Syncope

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet